Autophagy in cancer and chemotherapy

Shida Yousefi1, Hans-Uwe Simon

  • 1Institute of Pharmacology, University of Bern, Friedb0ihlstrasse 49, CH-3010 Bern, Switzerland.

Insights

Cancer cells resistant to apoptosis can die via autophagy, a backup cell death pathway. However, impaired autophagy in tumors can worsen drug resistance and genomic instability, necessitating new treatment strategies.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Cancer cells frequently develop mutations in apoptotic pathways, leading to resistance against conventional therapies.
  • Autophagic cell death presents an alternative cell death mechanism when apoptosis is compromised.
  • Tumor cells can also exhibit autophagy deficiencies, contributing to genomic instability and enhanced drug resistance.

Purpose of the Study:

  • To summarize the current understanding of autophagy regulation in tumors.
  • To explore novel anticancer drug treatment strategies targeting autophagy.

Main Methods:

  • Literature review and synthesis of current research on cancer cell death mechanisms.
  • Analysis of the role of autophagy in tumor progression and therapeutic resistance.

Main Results:

  • Apoptosis resistance is a hallmark of many cancers, making alternative cell death pathways like autophagy crucial.
  • Deficiencies in autophagy are observed in numerous tumors, exacerbating genomic instability and drug resistance.
  • Targeting autophagy presents a promising avenue for developing new anticancer therapies.

Conclusions:

  • Autophagy serves as a critical backup cell death mechanism in cancer, particularly when apoptosis fails.
  • Understanding and manipulating autophagy in tumors is essential for overcoming therapeutic resistance and improving patient outcomes.
  • Further research into autophagy modulation holds significant potential for innovative cancer treatment strategies.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...